Author

Sujan Kumar Dhar

Mazumdar Shaw Medical Foundation

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Manjula DasiD· 2 shared Chakenahalli N. Naveenkumar· 1 shared Gudepalya Renukaiah RudramurthyiD· 1 shared K. Bharathkumar· 1 shared Kiruthiga Raghunathan· 1 shared Kunal Biswas· 1 shared Naga Puspha Battula· 1 shared Pragnya Coca· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Manjula DasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rare case of Pediatric Male Secretory Breast Carcinoma: An Integrative study with Genomic and Transcriptomic analysis

Sohini Guha, Somrita Das, T Shashikumar, Kiruthiga Raghunathan, Pragnya Coca, Shobha Badiger, Sujan Kumar Dhar, Manjula Das

This study characterizes the genomic and transcriptomic features of a rare pediatric male secretory breast carcinoma, identifying actionable mutations and fusion events.

medRxiv · Nov 20, 2025 · PreprintGenetic & Genomic Medicine

Recombinant Human ACE2-Fc : A promising therapy for SARS-CoV2 infection

Smitha P.K., R.K. Shandil, Pushkarni Suresh, Kunal Biswas, Gudepalya Renukaiah Rudramurthy, Chakenahalli N. Naveenkumar, K. Bharathkumar, Naga Puspha Battula, Suprabuddha Datta Chowdhury, Sakshi Sinha, Sarmistha Dutta, Sujan Kumar Dhar, Shridhar Narayanan, Manjula Das

This paper describes a recombinant ACE2-Fc protein that neutralizes SARS-CoV2 in vitro and in vivo, with pharmacokinetic properties and a novel in vitro model for SARS-CoV2 infection.

bioRxiv · Jul 30, 2022 · PreprintMolecular Biology